Diabetes Care Devices – Market Insights – Asia Pacific (Supplemental)
The Asia Pacific diabetes care device market was impacted by COVID-19 in 2020. Beyond the pandemic, moderate growth is anticipated over the forecast period, driven by favorable demographics and the adoption of advanced products—such as hybrid closed-loop insulin pumps—that command a premium price. However, the markets—particularly in China and India—continue to be limited by strong cost constraints that impede the uptake of premium-priced products.
This Medtech 360 Report provides high-level market metrics for diabetes care devices in the Asia Pacific region, including country-level data for major countries and aggregate data for the rest of the Asia Pacific region from 2019 through 2031.
Table of contents
- Diabetes Care Devices - Market Insights - Asia Pacific (Supplemental)
- Abstract
- Key Report Updates
- COVID-19 Forecast Factors
- Diabetes Care Device Market
- Glucose Monitoring Device Market
- Market Definitions
- Market Forecast Data
- CAGR disclaimer
- Glucose Monitoring Device Market, by Product Type, Asia Pacific (USD), 2019u20132031
- Glucose Monitoring Device Market, by Product Type, Asia Pacific (USD), 2019u20132031
- Glucose Monitoring Device Market, by Country, Asia Pacific (USD), 2019u20132031
- Self-Monitoring Blood Glucose Devices
- Continuous Glucose Monitoring Devices
- Insulin Delivery Device Market
- Market Definitions
- Market Forecast Data
- CAGR disclaimer
- Insulin Delivery Device Market, by Product Type, Asia Pacific (USD), 2019u20132031
- Insulin Delivery Device Market, by Product Type, Asia Pacific (USD), 2019u20132031
- Insulin Delivery Device Market, by Country, Asia Pacific (USD), 2019u20132031
- Multiple Daily Injection Devices
- Conventional Pumps and Accessories
- Appendix